Status:

Red

Decision Date:

June 2020

Comments

RED¹: NICE TA656 - treating secondary progressive multiple sclerosis.  (Decision date - December 2020)

Red Drug Classifications

• 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
• 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again